Lantheus Holdings Inc (NASDAQ: LNTH) stock jumped 1.35% on Monday to $69.12 against a previous-day closing price of $68.20. With 0.53 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.96 million shares. During the session, the Drug Manufacturers – Specialty & Generic company that operates in wider Healthcare sector, reached to the highest price of $70.03 whereas the lowest price it dropped to was $68.05. The 52-week range on LNTH shows that it touched its highest point at $100.85 and its lowest point at $47.46 during that stretch. It currently has a 1-year price target of $113.23. Beta for the stock currently stands at 0.64.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of LNTH was up-trending over the past week, with a rise of 7.03%, but this was down by -0.70% over a month. Three-month performance surged to 2.63% while six-month performance fell -29.70%. The stock gained 25.42% in the past year, while it has gained 35.64% so far this year. A look at the trailing 12-month EPS for LNTH yields 1.43 with Next year EPS estimates of 6.13. For the next quarter, that number is 1.35. This implies an EPS growth rate of 38.32% for this year and 5.00% for next year. EPS is expected to grow by 37.73% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -33.99%.
Float and Shares Shorts:
At present, 68.85 million LNTH shares are outstanding with a float of 66.99 million shares on hand for trading. On Oct 30, 2023, short shares totaled 4.84 million, which was 7.07% higher than short shares on Sep 28, 2023. In addition to Ms. Mary Anne Heino as the firm’s CEO & Director, Mr. Paul M. Blanchfield serves as its President.
Institutional Ownership:
Through their ownership of 100.88% of LNTH’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 58.92% of LNTH, in contrast to 46.01% held by mutual funds. Shares owned by individuals account for 4.21%. As the largest shareholder in LNTH with 10.45% of the stake, BlackRock Fund Advisors holds 7,153,517 shares worth 7,153,517. A second-largest stockholder of LNTH, The Vanguard Group, Inc., holds 6,791,783 shares, controlling over 9.93% of the firm’s shares. Janus Henderson Investors US LLC is the third largest shareholder in LNTH, holding 3,058,133 shares or 4.47% stake. With a 3.14% stake in LNTH, the Vanguard Total Stock Market ETF is the largest stakeholder. A total of 2,147,212 shares are owned by the mutual fund manager. The iShares Core S&P Mid Cap ETF, which owns about 3.09% of LNTH stock, is the second-largest Mutual Fund holder. It holds 2,113,281 shares valued at 136.52 million. Vanguard Small Cap Index Fund holds 2.58% of the stake in LNTH, owning 1,765,051 shares worth 114.02 million.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for LNTH since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With LNTH analysts setting a high price target of $130.00 and a low target of $100.00, the average target price over the next 12 months is $113.23. Based on these targets, LNTH could surge 88.08% to reach the target high and rise by 44.68% to reach the target low. Reaching the average price target will result in a growth of 63.82% from current levels.
Summary of Insider Activity:
Insiders traded LNTH stock several times over the past three months with 2 Buys and 2 Sells. In these transactions, 7,718 shares were bought while 3,254 shares were sold. The number of buy transactions has increased to 25 while that of sell transactions has risen to 39 over the past year. The total number of shares bought during that period was 357,378 while 257,003 shares were sold.
